Thromboxane B2

• Catalog No.: 89227
• CAS Number: 54397-85-2
• M. F.: C20H34O6
• M. W.: 370.48036
• Purity: ≥98.0% (HPLC)

SYNONYMS

• IUPAC name: 7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid
• IUPAC Traditional name: 7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid
• Synonyms: (5Z,9α,11RS,13E,15S)-9,11,15-Trihydroxythromboxa-5,13-dien-1-oic acid; TXB2

DATABASE IDS

• CAS Number: 54397-85-2
• MDL Number: MFCD00135258

PROPERTIES

• Empirical Formula (Hill Notation): C20H34O6
• Purity: ≥98.0% (HPLC)
• GHS Signal Word: Warning
• GHS Hazard statements: H361
• European Hazard Symbols: Harmful (Xn)
• Personal Protective Equipment: Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
• GHS Precautionary statements: P281
• Risk Statements: 63
• Safety Statements: 22-36
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (English)

Biochem/physiol Actions
Prostaglandin derivative that is released during anaphylaxis; induces arterial contraction and platelet aggregation. Review of endogenous thromboxane B2 in risk analysis for development of thrombogenic disorders.1

Description (简体中文)

Biochem/physiol Actions
Prostaglandin derivative that is released during anaphylaxis; induces arterial contraction and platelet aggregation. Review of endogenous thromboxane B2 in risk analysis for development of thrombogenic disorders.1